Core Viewpoint - FOXO Technologies Inc. has expanded the clinical capabilities of its hospital subsidiary, Big South Fork Medical Center, by adding inpatient tele-specialty services and cardiac diagnostics, enhancing local patient care and reducing transfers [1][2][3] Company Developments - Big South Fork Medical Center, in partnership with Rural Physicians Group, now offers inpatient tele-specialty coverage in cardiology, pulmonology, and nephrology, allowing more patients to receive specialized care locally [2] - The hospital has implemented on-site echocardiography services and partnered with CompuMed for professional interpretation of echo studies, further improving diagnostic capabilities [2] - The Interim CEO of Big South Fork Medical Center emphasized that these additions will strengthen local treatment capabilities while ensuring clinical oversight [3] - FOXO's CEO highlighted the commitment to a technology-enabled care model that aims for long-term sustainability and increased net revenues for the hospital [3] Company Structure - FOXO Technologies Inc. operates four key subsidiaries, including Rennova Community Health, which owns Big South Fork Medical Center, a critical access designated hospital in East Tennessee [4] - Myrtle Recovery Centers, Inc. provides behavioral health services, while Vector BioSource, Inc. focuses on data and biospecimen sourcing for the biotechnology and pharmaceutical industries [5] - FOXO Labs, Inc. is dedicated to developing technology and product solutions aimed at improving human health and lifespan [6]

Core Viewpoint - FOXO Technologies Inc. has announced a 1 for 10 reverse stock split of its Class A common stock to comply with NYSE American listing requirements, effective April 28, 2025 [1][3]. Group 1: Reverse Stock Split Details - The reverse stock split was approved by stockholders at the Annual Meeting on November 29, 2024, with a ratio ranging from 1 for 5 to 1 for 100 [2]. - Every ten shares of Common Stock will be combined into one share, with no change in the par value of $0.0001 per share [2]. - Fractional shares will be rounded up to the next whole number for stockholders [2]. Group 2: Compliance and Impact - The reverse stock split aims to ensure compliance with NYSE American's requirement for a stock price above $0.10 [3]. - The company does not anticipate any impact on its current or future business operations due to the reverse stock split [3]. Group 3: Adjustments and Procedures - All outstanding stock options, warrants, and equity incentive plans will be proportionately adjusted according to their terms [4]. - Continental Stock Transfer & Trust Company will act as the exchange agent for the reverse stock split, providing instructions for stockholders regarding the exchange process [5]. Group 4: Company Overview - FOXO Technologies Inc. operates three subsidiaries: Rennova Community Health, Inc., Myrtle Recovery Centers, Inc., and Foxo Labs, Inc., focusing on healthcare and biotechnology [6][7].

Core Viewpoint - FOXO Technologies Inc. has filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, highlighting significant transitions and acquisitions that position the company for growth in 2025 [1][2][3]. Financial Reporting - The Annual Report includes an audit opinion from an independent registered public accounting firm, which contains an explanatory paragraph regarding FOXO's ability to continue as a going concern [2]. - The report does not amend or change the financial statements for the fiscal year ended December 31, 2024 [2]. Company Acquisitions and Growth Strategy - In 2024, FOXO completed the acquisitions of Myrtle Recovery Centers, Inc., a behavioral health business, and Rennova Community Health, Inc., which operates a rural hospital in Tennessee [3]. - The company believes it is well-positioned for growth from existing operations and potential acquisitions in 2025 [3]. Subsidiaries Overview - FOXO operates three subsidiaries: - Rennova Community Health, Inc., which owns and operates Scott County Community Hospital, a critical access hospital in East Tennessee [4]. - Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility providing various treatment services [4]. - FOXO Labs, Inc. focuses on biotechnology aimed at improving human health and lifespan through innovative technology [5].

As filed with the Securities and Exchange Commission on October 25, 2023 Registration No. 333-275072 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FOXO Technologies Inc. (Exact name of registrant as specified in its charter) Delaware 8731 85-1050265 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification ...